SYNLOGIC

Class [005]
Pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis and inflammatory pelvic diseases, autoimmune diseases and disorders, cancer and respiratory diseases and disorders; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of neurological diseases and disorders, namely Parkinson's disease, Alzheimer's disease, Huntington's disease, dementia, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of infectious diseases and disorders, namely influenza, cholera, malaria, meningitis, measles, hepatitis A, B, and C, West Nile virus and dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of genitourinary diseases and disorders, namely urological diseases and disorders; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of diseases and disorders namely, cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders and hepatic diseases and disorders; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of genetic diseases and disorders, namely phenylketonuria, muscular dystrophy, Turner syndrome, cystic fibrosis; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of metabolic diseases and disorders, namely growth and thyroid disorders, cycle disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management.